Last reviewed · How we verify
NCT03814369
AmplifEYE Colonoscopy vs Standard Colonoscopy
NA trial testing AmplifEYE in Colon Polyp in 355 participants. Completed in 30 November 2018.
30 June 2018
Quick facts
| Lead sponsor | Queen Elizabeth Hospital, Hong Kong |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 355 |
| Start date | 1 March 2017 |
| Primary completion | 30 June 2018 |
| Estimated completion | 30 November 2018 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- AmplifEYE
Conditions studied
- Colon Polyp — all drugs for Colon Polyp →
- Adenoma Colon — all drugs for Adenoma Colon →
- Serrated Polyp — all drugs for Serrated Polyp →
- Colonic Neoplasms — all drugs for Colonic Neoplasms →
Sponsor
Queen Elizabeth Hospital, Hong Kong
Who can join
Adults 50 to 79, any sex, with Colon Polyp or Adenoma Colon. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Colonoscopy screening is proven to reduce mortality rates for colorectal cancer, which relies on early detection and removal of colonic polyps. AmplifEYE is a FDA-approved device with a row of flexible detection arms attached to the tip of colonoscope which can separate colonic folds during scope withdrawal and is believed to improve polyp detection. Real-life clinical data on this relatively new device is lacking and this study aims to compare the adenoma and polyp detection rates in AmplifEYE-assisted colonoscopy versus standard colonoscopy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03814369
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colon Polyp
Currently open trials in the same condition.
- NCT06617468 — Effect of the Computer Aided Diagnosis with Explainable Artificial Intelligence for Colon Polyp on Optical Diagnosis and · NA · active not recruiting
- NCT06496958 — Water Exchange and CO2 Insufflation With Abdominal Compression Device to Reduce Manual Assistance · NA · recruiting
- NCT06073561 — Underwater Endoscopic Mucosal Resection · NA · recruiting
- NCT05990218 — Artificial Intelligence in the Detection of Right Sided Colonic Polyp in Different Operator Experience · NA · recruiting
- NCT05551052 — CRC Detection Reliable Assessment With Blood · active not recruiting
Other Queen Elizabeth Hospital, Hong Kong trials
Trials by the same sponsor.
- NCT04474002 — Efficacy, Tolerance and Safety of Split Dose Bowel Preparation for Colonoscopy: 4L Polyethylene Glycol (PEG) Versus 1L P · Phase 4 · completed
- NCT03082092 — Pre-operative Intravenous Steroid in Total Knee Replacement for Pain Relief and Recovery · Phase 4 · completed
- NCT03909841 — Neuropathic Pain in Elderly People With Diabetes: Impact on Quality of Life and Cognition · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03814369 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Queen Elizabeth Hospital, Hong Kong
- Last refreshed: 26 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03814369.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing